Katherine H. Schreiber

1.8k total citations
10 papers, 1.3k citations indexed

About

Katherine H. Schreiber is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Katherine H. Schreiber has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 1 paper in Cellular and Molecular Neuroscience and 1 paper in Health, Toxicology and Mutagenesis. Recurrent topics in Katherine H. Schreiber's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Muscle Physiology and Disorders (2 papers) and RNA Research and Splicing (2 papers). Katherine H. Schreiber is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Muscle Physiology and Disorders (2 papers) and RNA Research and Splicing (2 papers). Katherine H. Schreiber collaborates with scholars based in United States, Germany and China. Katherine H. Schreiber's co-authors include Brian K. Kennedy, Vivian L. MacKay, Warren Ladiges, Emmeline C. Academia, Chen‐Yu Liao, Matt Kaeberlein, Michael G. Garelick, Dao‐Fu Dai, Randy Strong and Steven C. Chen and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Katherine H. Schreiber

10 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine H. Schreiber United States 10 980 166 164 131 129 10 1.3k
Hanneke Okkenhaug United Kingdom 18 698 0.7× 255 1.5× 105 0.6× 268 2.0× 44 0.3× 30 1.1k
Barbara Kloeckener‐Gruissem Switzerland 22 1.1k 1.1× 146 0.9× 112 0.7× 65 0.5× 34 0.3× 42 1.7k
Ruilin Tian China 14 1.1k 1.1× 273 1.6× 261 1.6× 152 1.2× 156 1.2× 30 1.5k
Yolanda Cámara Spain 19 1.5k 1.5× 75 0.5× 202 1.2× 86 0.7× 56 0.4× 35 1.7k
Jukka Kallijärvi Finland 19 753 0.8× 95 0.6× 99 0.6× 96 0.7× 22 0.2× 41 1.1k
David T. Madden United States 12 775 0.8× 445 2.7× 299 1.8× 109 0.8× 78 0.6× 15 1.3k
Rafal Czapiewski United Kingdom 13 714 0.7× 68 0.4× 353 2.2× 63 0.5× 159 1.2× 17 998
Ofer Moldavski United States 10 652 0.7× 289 1.7× 152 0.9× 159 1.2× 60 0.5× 11 970
Jung Hwan Kim United States 19 780 0.8× 318 1.9× 154 0.9× 50 0.4× 19 0.1× 31 1.1k
Christine Powers United States 20 768 0.8× 331 2.0× 117 0.7× 345 2.6× 31 0.2× 23 1.3k

Countries citing papers authored by Katherine H. Schreiber

Since Specialization
Citations

This map shows the geographic impact of Katherine H. Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine H. Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine H. Schreiber more than expected).

Fields of papers citing papers by Katherine H. Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine H. Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine H. Schreiber. The network helps show where Katherine H. Schreiber may publish in the future.

Co-authorship network of co-authors of Katherine H. Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine H. Schreiber. A scholar is included among the top collaborators of Katherine H. Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine H. Schreiber. Katherine H. Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sánchez, María Álvarez, Kizito‐Tshitoko Tshilenge, Jordi Creus‐Muncunill, et al.. (2021). Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels. Autophagy. 17(12). 4119–4140. 39 indexed citations
2.
Powers, Samantha K., Alex S. Holehouse, David A. Korasick, et al.. (2019). Nucleo-cytoplasmic Partitioning of ARF Proteins Controls Auxin Responses in Arabidopsis thaliana. Molecular Cell. 76(1). 177–190.e5. 180 indexed citations
3.
Schreiber, Katherine H., Sebastian I. Arriola Apelo, Deyang Yu, et al.. (2019). A novel rapamycin analog is highly selective for mTORC1 in vivo. Nature Communications. 10(1). 3194–3194. 132 indexed citations
4.
Riley, Rebeccah, Monique N. O’Leary, Katherine H. Schreiber, et al.. (2017). mTORC1 Activation during Repeated Regeneration Impairs Somatic Stem Cell Maintenance. Cell stem cell. 21(6). 806–818.e5. 82 indexed citations
5.
Schreiber, Katherine H., et al.. (2015). Rapamycin‐mediated mTORC 2 inhibition is determined by the relative expression of FK 506‐binding proteins. Aging Cell. 14(2). 265–273. 129 indexed citations
6.
Oleson, Bryndon J., Katarzyna A. Broniowska, Katherine H. Schreiber, Vera L. Tarakanova, & John A. Corbett. (2014). Nitric Oxide Induces Ataxia Telangiectasia Mutated (ATM) Protein-dependent γH2AX Protein Formation in Pancreatic β Cells. Journal of Biological Chemistry. 289(16). 11454–11464. 26 indexed citations
7.
Schreiber, Katherine H. & Brian K. Kennedy. (2013). When Lamins Go Bad: Nuclear Structure and Disease. Cell. 152(6). 1365–1375. 288 indexed citations
8.
O’Leary, Monique N., Katherine H. Schreiber, Yong Zhang, et al.. (2013). The Ribosomal Protein Rpl22 Controls Ribosome Composition by Directly Repressing Expression of Its Own Paralog, Rpl22l1. PLoS Genetics. 9(8). e1003708–e1003708. 97 indexed citations
9.
Garelick, Michael G., Vivian L. MacKay, Emmeline C. Academia, et al.. (2013). Chronic rapamycin treatment or lack ofS6K1does not reduce ribosome activity in vivo. Cell Cycle. 12(15). 2493–2504. 22 indexed citations
10.
Ramos, Fresnida J., Steven C. Chen, Michael G. Garelick, et al.. (2012). Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C–Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival. Science Translational Medicine. 4(144). 144ra103–144ra103. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanneke Okkenhaug Breakdown of academic impact, for papers by Barbara Kloeckener‐Gruissem Breakdown of academic impact, for papers by Ruilin Tian Breakdown of academic impact, for papers by Yolanda Cámara Breakdown of academic impact, for papers by Jukka Kallijärvi Breakdown of academic impact, for papers by David T. Madden Breakdown of academic impact, for papers by Rafal Czapiewski Breakdown of academic impact, for papers by Ofer Moldavski Breakdown of academic impact, for papers by Jung Hwan Kim Breakdown of academic impact, for papers by Christine Powers
Rankless by CCL
2026